Financial Synergies Wealth Advisors, Inc.
13F filer · CIK 0002017868Reported Jul 17, 2026
Net buyer this quarter
13F portfolio value$1.18BU.S. long equity reported on 13F
Positions526 new · 1 closed
Net flow last quarter+$2.34MBuys minus sells
Top 10 positions weight7.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 17, 202652 positions | |||||
| $19.8M | 1.68% | 0.00% | +1.3% | Q2 2022 | |
| $12.5M | 1.06% | 0.00% | -2.4% | Q4 2019 | |
| $11M | 0.93% | 0.00% | +14.5% | Q1 2026 | |
| $9.96M | 0.84% | Not reported | -2.0% | Q2 2019 | |
| $9.6M | 0.81% | 0.00% | 0.0% | Q2 2022 | |
| $6.96M | 0.59% | 0.00% | +0.2% | Q4 2025 | |
| $6.6M | 0.56% | 0.00% | -7.6% | Q1 2019 | |
| $3.32M | 0.28% | 0.00% | -0.7% | Q4 2022 | |
| $3.02M | 0.26% | 0.01% | 0.0% | Q4 2025 | |
| $2.62M | 0.22% | 0.00% | +0.5% | Q2 2022 | |
| $2.39M | 0.20% | 0.00% | +0.1% | Q2 2022 | |
| $2.29M | 0.19% | 0.00% | -14.0% | Q1 2019 | |
| $2.2M | 0.19% | 0.00% | +1.1% | Q1 2021 | |
| $2.14M | 0.18% | 0.00% | +1.0% | Q1 2020 | |
| $2.1M | 0.18% | Not reported | -1.1% | Q2 2019 | |
| $2.03M | 0.17% | Not reported | -5.9% | Q2 2020 | |
| $2M | 0.17% | 0.00% | +14.8% | Q2 2022 | |
| $1.96M | 0.17% | Not reported | -38.7% | Q1 2019 | |
| $1.75M | 0.15% | 0.00% | +3.5% | Q4 2019 | |
| $1.71M | 0.14% | Not reported | +0.7% | Q2 2020 | |
| PBPMBSPuramed Bioscience Inc. | $1.7M | 0.14% | 0.02% | +36.1% | Q3 2025 |
| $1.48M | 0.13% | 0.00% | +13.6% | Q2 2022 | |
| $1.35M | 0.11% | 0.00% | +18.1% | Q1 2020 | |
| $1.3M | 0.11% | 0.00% | +10.6% | Q2 2022 | |
| $1.25M | 0.11% | 0.00% | +138.1% | Q2 2022 | |
| $1.04M | 0.09% | 0.00% | +14.7% | Q4 2025 | |
| $1.03M | 0.09% | 0.00% | +23.7% | Q2 2022 | |
| $845K | 0.07% | Not reported | +24.6% | Q4 2025 | |
| $818K | 0.07% | 0.00% | +4.0% | Q2 2022 | |
| $794K | 0.07% | 0.00% | -5.2% | Q2 2022 | |
| $752K | 0.06% | Not reported | -2.1% | Q2 2020 | |
| $710K | 0.06% | 0.00% | +5.6% | Q1 2019 | |
| $632K | 0.05% | 0.00% | +10.7% | Q2 2022 | |
| $556K | 0.05% | 0.00% | +2.4% | Q2 2022 | |
| $539K | 0.05% | 0.00% | -4.9% | Q2 2022 | |
| $528K | 0.04% | Not reported | Not reported | Q4 2025 | |
| $462K | 0.04% | 0.00% | +4.5% | Q1 2026 | |
| $451K | 0.04% | 0.00% | +2.2% | Q4 2022 | |
| $439K | 0.04% | 0.00% | -50.0% | Q1 2026 | |
| $435K | 0.04% | 0.00% | Not reported | Q1 2023 | |
| $415K | 0.04% | 0.00% | +8.5% | Q2 2022 | |
| $367K | 0.03% | 0.00% | +4.6% | Q3 2021 | |
| $276K | 0.02% | 0.00% | +13.2% | Q3 2022 | |
| $274K | 0.02% | Not reported | +0.2% | Q2 2022 | |
| $273K | 0.02% | 0.00% | New | Q2 2026 | |
| $250K | 0.02% | Not reported | Not reported | Q2 2022 | |
| $221K | 0.02% | 0.00% | +10.6% | Q2 2022 | |
| $216K | 0.02% | 0.00% | Not reported | Q2 2022 | |
| $212K | 0.02% | 0.00% | -13.3% | Q3 2023 | |
| $205K | 0.02% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported May 14, 202647 positions | |||||
| $11.2M | 1.07% | 0.00% | +94.2% | Q4 2019 | |
| $9.43M | 0.90% | Not reported | -1.8% | Q2 2019 | |
| $8.87M | 0.85% | 0.00% | -0.4% | Q1 2019 | |
| $6.38M | 0.61% | 0.00% | +16.6% | Q2 2022 | |
| $5.71M | 0.55% | 0.00% | +266.9% | Q2 2022 | |
| $3.67M | 0.35% | 0.00% | -3.3% | Q4 2022 | |
| $3.32M | 0.32% | 0.00% | -4.7% | Q1 2019 | |
| $2.94M | 0.28% | 0.00% | +767.1% | Q4 2025 | |
| $2.79M | 0.27% | Not reported | +2.9% | Q1 2019 | |
| $2.77M | 0.26% | 0.00% | Not reported | Q2 2022 | |
| $2.68M | 0.26% | 0.00% | New | Q1 2026 | |
| $2.64M | 0.25% | 0.01% | +82.2% | Q4 2025 | |
| $2.26M | 0.22% | 0.00% | +171.9% | Q2 2022 | |
| $2.1M | 0.20% | 0.00% | +15.2% | Q1 2020 | |
| $2.04M | 0.19% | Not reported | +37.6% | Q2 2019 | |
| $1.69M | 0.16% | Not reported | +44.5% | Q2 2020 | |
| $1.63M | 0.16% | 0.00% | -1.4% | Q4 2019 | |
| $1.59M | 0.15% | Not reported | -4.5% | Q2 2020 | |
| $1.52M | 0.15% | 0.00% | +17.6% | Q2 2022 | |
| $1.42M | 0.14% | 0.00% | -1.1% | Q1 2021 | |
| PBPMBSPuramed Bioscience Inc. | $1.26M | 0.12% | 0.01% | +37.0% | Q3 2025 |
| $1.17M | 0.11% | 0.00% | +258.5% | Q2 2022 | |
| $1.03M | 0.10% | 0.01% | New | Q1 2026 | |
| $1M | 0.10% | 0.00% | -1.9% | Q1 2020 | |
| $962K | 0.09% | 0.00% | +2.6% | Q2 2022 | |
| $918K | 0.09% | 0.00% | +84.9% | Q4 2025 | |
| $821K | 0.08% | 0.00% | +118.5% | Q2 2022 | |
| $732K | 0.07% | Not reported | Not reported | Q2 2020 | |
| $693K | 0.07% | 0.00% | Not reported | Q1 2019 | |
| $680K | 0.06% | 0.00% | -3.5% | Q2 2022 | |
| $662K | 0.06% | 0.00% | -21.7% | Q2 2022 | |
| $633K | 0.06% | 0.00% | -14.5% | Q2 2022 | |
| $572K | 0.05% | Not reported | -0.1% | Q4 2025 | |
| $551K | 0.05% | Not reported | +145.4% | Q4 2025 | |
| $500K | 0.05% | 0.00% | +2.8% | Q2 2022 | |
| $465K | 0.04% | 0.00% | +7.5% | Q2 2022 | |
| $403K | 0.04% | 0.00% | -26.5% | Q1 2019 | |
| $394K | 0.04% | 0.00% | +0.8% | Q4 2022 | |
| $328K | 0.03% | 0.00% | New | Q1 2026 | |
| $266K | 0.03% | 0.00% | Not reported | Q3 2021 | |
| $252K | 0.02% | 0.00% | -19.6% | Q2 2022 | |
| $244K | 0.02% | 0.00% | +1.8% | Q3 2023 | |
| $243K | 0.02% | Not reported | Not reported | Q2 2022 | |
| $241K | 0.02% | 0.00% | -17.2% | Q3 2022 | |
| $235K | 0.02% | Not reported | +8.6% | Q2 2022 | |
| $217K | 0.02% | 0.00% | Not reported | Q2 2022 | |
| $204K | 0.02% | 0.00% | Not reported | Q2 2022 | |
| Q4 2025Reported Feb 6, 202642 positions | |||||
| $8.87M | 0.86% | Not reported | +0.8% | Q2 2019 | |
| $6.31M | 0.61% | 0.00% | +3.5% | Q1 2019 | |
| $6.2M | 0.60% | 0.00% | +10.3% | Q4 2019 | |
| $4.43M | 0.43% | 0.00% | +175.0% | Q2 2022 | |
| $3.4M | 0.33% | 0.00% | +4.0% | Q4 2022 | |
| $2.84M | 0.27% | Not reported | -19.8% | Q1 2019 | |
| $2.57M | 0.25% | 0.00% | +1.7% | Q1 2019 | |
| $2.38M | 0.23% | 0.00% | +22.1% | Q1 2020 | |
| $1.75M | 0.17% | 0.00% | +0.5% | Q1 2021 | |
| $1.64M | 0.16% | Not reported | +1.0% | Q2 2020 | |
| $1.55M | 0.15% | Not reported | +24.6% | Q2 2019 | |
| $1.45M | 0.14% | 0.01% | New | Q4 2025 | |
| $1.4M | 0.14% | 0.00% | +0.6% | Q4 2019 | |
| $1.38M | 0.13% | 0.00% | +9.0% | Q2 2022 | |
| $1.32M | 0.13% | 0.00% | Not reported | Q2 2022 | |
| $1.24M | 0.12% | Not reported | +22.1% | Q2 2020 | |
| $1.13M | 0.11% | 0.00% | +17.9% | Q1 2020 | |
| $923K | 0.09% | 0.00% | +0.7% | Q2 2022 | |
| PBPMBSPuramed Bioscience Inc. | $919K | 0.09% | 0.01% | +56.2% | Q3 2025 |
| $806K | 0.08% | 0.00% | +46.8% | Q2 2022 | |
| $787K | 0.08% | 0.00% | +101.9% | Q2 2022 | |
| $779K | 0.08% | 0.00% | +0.4% | Q2 2022 | |
| $724K | 0.07% | Not reported | +1.9% | Q2 2020 | |
| $684K | 0.07% | 0.00% | New | Q4 2025 | |
| $607K | 0.06% | Not reported | New | Q4 2025 | |
| $548K | 0.05% | 0.00% | Not reported | Q2 2022 | |
| $530K | 0.05% | 0.00% | +3.7% | Q2 2022 | |
| $523K | 0.05% | 0.00% | +23.4% | Q2 2022 | |
| $499K | 0.05% | 0.00% | Not reported | Q2 2022 | |
| $389K | 0.04% | 0.00% | +1.0% | Q1 2019 | |
| $372K | 0.04% | 0.00% | +1.3% | Q4 2022 | |
| $358K | 0.03% | 0.00% | +0.9% | Q2 2022 | |
| $312K | 0.03% | 0.00% | +0.9% | Q2 2022 | |
| $288K | 0.03% | 0.00% | +53.9% | Q3 2022 | |
| $266K | 0.03% | 0.00% | -0.2% | Q3 2023 | |
| $245K | 0.02% | Not reported | New | Q4 2025 | |
| $235K | 0.02% | 0.00% | -2.6% | Q4 2022 | |
| $231K | 0.02% | 0.00% | +0.9% | Q2 2022 | |
| $222K | 0.02% | 0.00% | Not reported | Q2 2022 | |
| $216K | 0.02% | 0.00% | New | Q4 2025 | |
| $210K | 0.02% | Not reported | Not reported | Q2 2022 | |
| $202K | 0.02% | 0.00% | Not reported | Q2 2022 | |
| Q3 2025Reported Oct 27, 202532 positions | |||||
| $8.37M | 0.85% | Not reported | -2.9% | Q2 2019 | |
| $5.71M | 0.58% | 0.00% | +0.2% | Q1 2019 | |
| $5.27M | 0.53% | 0.00% | -4.8% | Q4 2019 | |
| $3.46M | 0.35% | Not reported | +0.7% | Q1 2019 | |
| $3.02M | 0.31% | 0.00% | -0.9% | Q4 2022 | |
| $2.58M | 0.26% | 0.00% | +0.3% | Q1 2019 | |
| $2.09M | 0.21% | 0.00% | +1.4% | Q1 2020 | |
| $1.82M | 0.18% | 0.00% | +0.4% | Q1 2021 | |
| $1.58M | 0.16% | Not reported | -2.7% | Q2 2020 | |
| $1.34M | 0.14% | 0.00% | +0.6% | Q2 2022 | |
| $1.27M | 0.13% | 0.00% | -0.5% | Q2 2022 | |
| $1.25M | 0.13% | Not reported | -0.9% | Q2 2019 | |
| $1.25M | 0.13% | 0.00% | +1.1% | Q4 2019 | |
| $994K | 0.10% | Not reported | +1.7% | Q2 2020 | |
| $912K | 0.09% | 0.00% | +2.9% | Q1 2020 | |
| $911K | 0.09% | 0.00% | +0.6% | Q2 2022 | |
| $703K | 0.07% | Not reported | Not reported | Q2 2020 | |
| $695K | 0.07% | 0.00% | -14.2% | Q2 2022 | |
| PBPMBSPuramed Bioscience Inc. | $588K | 0.06% | 0.01% | New | Q3 2025 |
| $508K | 0.05% | 0.00% | -13.0% | Q2 2022 | |
| $426K | 0.04% | 0.00% | +20.5% | Q2 2022 | |
| $419K | 0.04% | 0.00% | -31.6% | Q2 2022 | |
| $389K | 0.04% | 0.00% | +1.4% | Q1 2019 | |
| $376K | 0.04% | 0.00% | +0.8% | Q4 2022 | |
| $372K | 0.04% | 0.00% | -10.6% | Q2 2022 | |
| $347K | 0.04% | 0.00% | -12.2% | Q2 2022 | |
| $274K | 0.03% | 0.00% | +1.6% | Q2 2022 | |
| $269K | 0.03% | 0.00% | +7.4% | Q2 2022 | |
| $264K | 0.03% | 0.00% | +2.4% | Q3 2023 | |
| $208K | 0.02% | 0.00% | Not reported | Q4 2022 | |
| $202K | 0.02% | 0.00% | Not reported | Q2 2022 | |
| $201K | 0.02% | 0.00% | Not reported | Q3 2022 | |
Premium opens every quarter this fund has filed